Use of Antibiotic Carrier in Acute Periprosthetic Infections (APPI) of Total Knee Replacements
Use of Antibiotic Contained Calcium Sulfate Carrier in Acute Periprosthetic Infections(APPI) of Total Knee Replacements
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Southwest Orthopedic Group, LLP
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- APPI within 28 days of primary TKR
- Acute hematogenous infection within 4 weeks of symptoms
Exclusion Criteria:
- Exposed prosthesis
- Infection occuring in revised joints
- Poly articular infections
- have allergies to tobramycin or Vancomycin
- previous chronic infections in or around any ipsilateral extremity trauma or implants
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
APPI of TKR-Stimulan
Surgery Stimulan beads 2.4 G Tobramycin 2.0 G Vancomycin
|
Other Names:
|
|
APPI of TKR-historical
Surgery 2.4 G Tobramycin 2.0 G Vancomycin
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Retention of components
Time Frame: 12 months
|
12 months
|
|
Eradication of infection
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
C-Reactive protein (CRP)
Time Frame: 12 months
|
12 months
|
|
Wound complications
Time Frame: 12 months
|
12 months
|
|
Knee Society Score
Time Frame: 12 months
|
12 months
|
|
Visual Analog Scale
Time Frame: 12 months
|
12 months
|
|
Outcome Assessment Scores
Time Frame: 12 months
|
12 months
|
|
Ongoing use of antibiotics
Time Frame: 6 weeks
|
6 weeks
|
|
AP and lateral Radiographs of involved joint
Time Frame: 12 months
|
12 months
|
|
Positive synovial fluid cell count
Time Frame: pre-operative
|
pre-operative
|
|
Sedimentation Rate
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Michael P Muldoon, MD, Sharp Healthcare
- Principal Investigator: David R Lionberger, MD, Southwest Orthopedic Group, LLC
Publications and helpful links
General Publications
- Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CG. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011 Nov;469(11):2992-4. doi: 10.1007/s11999-011-2102-9. No abstract available.
- Mortazavi SM, Vegari D, Ho A, Zmistowski B, Parvizi J. Two-stage exchange arthroplasty for infected total knee arthroplasty: predictors of failure. Clin Orthop Relat Res. 2011 Nov;469(11):3049-54. doi: 10.1007/s11999-011-2030-8.
- Koyonos L, Zmistowski B, Della Valle CJ, Parvizi J. Infection control rate of irrigation and debridement for periprosthetic joint infection. Clin Orthop Relat Res. 2011 Nov;469(11):3043-8. doi: 10.1007/s11999-011-1910-2.
- Gardner J, Gioe TJ, Tatman P. Can this prosthesis be saved?: implant salvage attempts in infected primary TKA. Clin Orthop Relat Res. 2011 Apr;469(4):970-6. doi: 10.1007/s11999-010-1417-2.
- Estes CS, Beauchamp CP, Clarke HD, Spangehl MJ. A two-stage retention debridement protocol for acute periprosthetic joint infections. Clin Orthop Relat Res. 2010 Aug;468(8):2029-38. doi: 10.1007/s11999-010-1293-9.
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1112-0211
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.